Pemi Strips Review: Luna, Clara and Sera Labels
A label-first look at Pemi's three perimenopause strips, with dose matches, evidence gaps, safety flags and the price you actually pay.
| Dose fit | Luna's 28mg Affron dose matches the 28mg/day used in a 12-week perimenopause trial. Clara's cognitive ingredients and Sera's L-theanine, tryptophan and lavender are below common research doses; the page does not supply a dose-matched perimenopause study for the finished blends. |
|---|---|
| Evidence fit | Luna has relevant single-ingredient evidence for psychological symptoms in perimenopause, but it did not outperform placebo for vasomotor or somatic symptoms. No relevant study of finished Pemi Luna, Clara or Sera strips was found. The strips themselves have no independent hands-on review. |
| Safety flags | Sera can add to daytime drowsiness from other sedatives or sleep medicines; melatonin use needs a medication review, especially with blood thinners or epilepsy. Clara combines several cognitive ingredients, and its dopaminergic effects warrant care with medicines. Check the full label and clinician/pharmacist advice if pregnant, breastfeeding, managing hormone-sensitive history, or taking prescription drugs. |
| The negative case | The format is convenient and Luna's saffron dose is a real research match, but no finished strip has been tested in a perimenopause trial. Clara and Sera lean on small ingredient amounts, making marketing claims harder to justify. There is no independent hands-on review, and the full bundle is the most expensive way to try the range. |
Pemi strips review: Luna has the strongest research fit
If mood, focus and sleep have all shifted at once, a day-by-day routine sounds sensible. Three little strips that melt in your mouth are easier to carry than a bottle of pills. That convenience is real. So is the gap between an easy-to-use label and a formula proven for perimenopause.
Pemi launched Luna, Clara and Sera on September 4, 2026. The company positions them for mood, mental clarity and restful sleep. PeriProof did not test or take the strips. We found no independent hands-on review, only company pages, the paid launch release and online customer reviews hosted by the brand.
That distinction matters. A launch release proves what the company said. It does not prove the products work.
The claim: three symptoms, three packets
The strips dissolve on the tongue in about 30 seconds, need no water and are individually wrapped. Pemi says consistency matters and recommends using a product daily. Its own disclaimers say the structure/function claims have not been evaluated by the FDA and the products are not intended to diagnose, treat, cure or prevent disease.[1][2]
“Clinically studied” is also narrower than it sounds. The current pages do cite research around individual ingredients. They do not show a clinical trial of a finished Pemi strip, and “100% science-backed” on the home page does not resolve that difference.[1]
Label check: three different strength stories
Luna: the cleanest research match
Luna lists:
- 28mg Affron® saffron extract
- 50mg L-theanine
- 10mg vitamin B6
The saffron dose is the important part. A 12-week, randomized, placebo-controlled trial in 86 perimenopausal women used 14mg Affron twice daily, 28mg total. It found greater improvement in psychological symptoms than placebo, including anxiety and depression measures. It did not find greater improvement in vasomotor symptoms, somatic symptoms or broader quality-of-life measures.[3]
So Luna matches a studied dose, but the study tested saffron alone over 12 weeks, not Affron plus 50mg L-theanine plus 10mg B6 in a dissolving strip. No relevant finished-product study was found.
Clara: transparency, but tiny cognitive doses
Clara lists:
- 25mg citicoline
- 25mg alpha-GPC
- 10mg N-acetyl-L-tyrosine
- 1.7mg vitamin B6
- 250mcg vitamin B12
Pemi calls the blend “thoughtfully formulated,” not clinically studied. The doses are visible, which is better than a proprietary blend. But 25mg citicoline and 25mg alpha-GPC are modest amounts. Research on these ingredients does not establish that this small combined dose improves perimenopausal brain fog. No dose-matched study of the finished strip was found.
A broad choline-supplement review reports cognition research, but also emphasizes the wide variation among forms, doses, conditions and study results.[4] Clara’s website should be read as a marketing rationale, not a clinical result.
Sera: melatonin leads a small blend
Sera lists:
- 3mg melatonin
- 50mg L-theanine
- 20mg L-tryptophan
- 10mg lavender extract
Melatonin is a circadian timing signal, not a general knockout pill. NCCIH says evidence supports it for conditions such as jet lag and delayed sleep-wake phase disorder. For chronic insomnia, major guidelines cited by NCCIH find insufficient strong evidence, and long-term safety data are lacking.[5]
The other ingredients are recognizable, but their doses are not the usual high end of sleep research. Pemi provides no perimenopause study of the blend. No relevant finished-product study was found. The perimenopause sleep supplement guide explains why timing and the reason behind poor sleep matter more than the word “sleep” on a pouch.
The negative case
You are paying for a well-presented convenience format and a brand-specific routine built from ingredient-level evidence, not product-level proof.
Clara and Sera may be the weakest fits because their active ingredients are low relative to much of the research commonly cited for those ingredients. Buying all three also makes attribution harder. If mood improves, was it Luna? If sleep changes, was it melatonin, the wind-down routine, or getting up at a steadier time?
Sera deserves the most interaction attention. Melatonin can cause headache, dizziness, nausea or sleepiness, and NCCIH flags extra caution for people with epilepsy or those taking blood thinners. L-theanine may add to the effect of sedatives or sleep medicines.[5][6] Clara’s dopaminergic ingredients and Sera’s calming ingredients also belong in one complete medication review, especially if you take prescription drugs, are pregnant or breastfeeding, or have hormone-sensitive medical history. “No hormones” on a label would not settle those questions anyway.
These strips do not replace medical care. New or severe mood symptoms, heavy bleeding, hot flashes, or insomnia that keeps returning deserve a clinical conversation.
The real cost: the bundle is the expensive trial
Current one-time prices on Pemi’s product pages work out to:
- Luna: $60 for 30 strips, or $2.00/day
- Clara: $45 for 30 strips, or $1.50/day
- Sera: $45 for 30 strips, or $1.50/day
- 30-day Protocol Bundle: $130 for 30 of each, or $4.33/day
The bundle saves $15 against buying one 30-day box of each. The listed 90-day prices for the individual products equal three 30-day boxes, so they do not show an extra per-day saving.[1][2]
The product pages mention membership benefits and say deliveries can be skipped or canceled. However, no recurring-plan price, renewal amount or discount was visible in the product data reviewed. The 90-Day Promise also applies only to qualifying members who use the selected product as directed. Read checkout terms before relying on either offer.
For a first look, buying one 30-day box is the cleaner experiment than committing to all three. Our perimenopause supplement stack guide also makes the case for one symptom and one job at a time.
What we still do not know
- No finished Pemi strip has a located perimenopause trial.
- No independent hands-on review of taste, dissolving time or dose accuracy was found.
- The public pages do not provide a certificate of analysis or third-party test result for the finished strips.
- “No water” and “melts in about 30 seconds” describe the format, not better clinical outcomes.
- No verified affiliate offer is listed, so this review contains no affiliate link.
The honest read is simple. Luna has the best dose-to-evidence connection. Clara and Sera are transparent but under-claim-worthy. If convenience is what you are buying, the strips deliver that. If you are buying proven perimenopause relief, the evidence does not go that far.